FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · EUROPEAN MEDICINES AGENCY: NEWS · 1 October 2026

Advice on ‘end-of-year’ submission dates for type I variations in 2026

Synopsis

Marketing authorisation holders are advised to submit any type IB variations or groupings of type IBs and type IAs by 30 November 2026 for a start of procedure in 2026. This may impact our usual timelines for validation and responses to queries for all type I variations (IA and IB).

Automatically extracted from the original page. This is a short summary, not the full story, and may omit important detail.

Read the full story at European Medicines Agency: news ↗

More in New medicines and drug discovery